English
BPC-157 5mg TB-500 5mg Peptide Blend combines two peptide components in one product configuration. The listed composition comprises 5mg of BPC-157 and 5mg of TB-500 per unit. For procurement teams, this defined ratio provides a clear starting point for reviewing the product identity, packaging configuration and documentation before placing an order.
BPC-157 and TB-500 have been discussed in preclinical research relating to biological processes such as tissue response, cell migration and repair-associated pathways. However, findings from experimental models do not establish clinical efficacy or safety in humans. The combination should not be assumed to produce a particular synergistic effect without product-specific and combination-specific evidence.
JinBei supports international buyers with product information, available quality documentation and order coordination. Buyers can confirm the applicable specifications, packaging and analytical information before making a purchasing decision.
The product is identified by two components: BPC-157 and TB-500. Each is listed at 5mg, providing a stated 1:1 ratio by weight. Buyers should verify the actual composition and quantities against the product label and applicable COA.
The product name identifies the stated quantity of each peptide rather than presenting only a combined total. This makes the intended composition easier to review during product comparison, purchasing approval and inventory documentation.
JinBei can provide available COA documentation to help buyers review reported product information. Before ordering, purchasers should confirm which analytical tests are included, whether the reported values are batch-specific, and whether the documentation meets their internal quality requirements.
Different buyers may need to evaluate a product before considering larger quantities. JinBei supports sample inquiries and bulk purchasing discussions, with final order quantities, pricing and availability confirmed individually.
For overseas buyers, procurement involves more than product selection. Packaging, shipping arrangements, export documentation and destination-specific requirements may all affect an order. JinBei can coordinate these details during the quotation and order-confirmation process.
The two components have been investigated separately in preclinical research, although their research histories and proposed biological mechanisms are not identical.
BPC-157 is an experimental peptide that has been studied in preclinical models involving tissue-related biological responses and repair-associated pathways. Findings from these studies should be interpreted within the limits of the specific experimental models and should not be treated as proof of a therapeutic effect in humans.
TB-500 is a name used in peptide-product contexts associated with thymosin beta-4-related research. The precise sequence and identity of the material supplied under this name should be verified through product-specific documentation rather than assumed from the name alone.
This product is presented as a two-component peptide blend with a stated 5mg + 5mg composition. The combination itself should not be described as clinically proven to accelerate tissue regeneration, repair tendons, heal wounds or relieve inflammation without appropriate evidence supporting those claims.
For research-material buyers, confirming the identity of each component, stated content, analytical documentation and storage requirements is more useful than relying on broad claims about combined biological effects.
|
Form |
Paste |
|
Color |
light yellow |
The product name specifies BPC-157 at 5mg and TB-500 at 5mg, representing a stated 1:1 weight ratio. Buyers should verify the actual content and product configuration against the label and applicable COA.
COA documentation is available. Please request the relevant product documentation to confirm the reported analytical information and whether it meets your purchasing or research requirements.
Sample inquiries are accepted. Samples are chargeable according to the applicable price list, and availability, sample quantity and shipping costs should be confirmed with JinBei.
The MOQ for this specific product has not been confirmed in the supplied information. Please contact JinBei to verify the minimum order, packaging configuration and quantity per box.
The current source information does not reliably confirm whether this blend is supplied as a powder, lyophilized material or another form. Please refer to the product-specific specification and label before ordering.
Storage conditions should follow the confirmed product label and handling documentation. Because the storage requirements for this particular blend have not been provided, buyers should obtain the applicable instructions before arranging storage.
Yes. JinBei has an office in Shanghai, China. Buyers can contact the company to discuss product documentation, purchasing requirements and order coordination.
Factory visits are temporarily unavailable under the current site-visit arrangements. Please contact JinBei for product information and purchasing discussions.
International shipping arrangements can be discussed when the order is confirmed. Available options, documentation and delivery schedules depend on the destination country and the specific order requirements.
Address
No. 1599, Pingzhuang West Road, Fengxian District, Shanghai City, China
Tel
